A Closer Look at 4 Analyst Recommendations For Elanco Animal Health
Portfolio Pulse from Benzinga Insights
Over the past three months, analysts have provided mixed evaluations for Elanco Animal Health (NYSE:ELAN), with ratings ranging from somewhat bullish to indifferent. The average 12-month price target is $19.75, with a high of $23.00 and a low of $16.00. Recent financial performance shows a decline in revenue growth but strong net margins and return on equity.
July 01, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have mixed views on Elanco Animal Health, with recent ratings ranging from somewhat bullish to indifferent. The average 12-month price target is $19.75. Financial performance shows a decline in revenue growth but strong net margins and return on equity.
The mixed analyst ratings and stable average price target suggest a neutral short-term impact on ELAN's stock price. The decline in revenue growth is a concern, but strong net margins and ROE provide a positive counterbalance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100